Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 14 of 15
Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery
NCT00161577
Evaluation of Lungs of Normal Individuals by Lung Lavage, Brushing and Bronchial Wall Biopsy
NCT00224185
Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
NCT00151320
Evaluation of the Lungs of Individuals With Lung Disease
NCT00224198
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
NCT00195013
Effectiveness of Propranolol For Treating People With Post-Traumatic Stress Disorder
NCT00648375
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
NCT00774202
Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy
NCT00194870
Combined Spinal-Epidural Versus Traditional Labor Epidural
NCT00151346
Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML
NCT00195104
Treatment Choices for Improving Adherence and Outcome
NCT00194948
Islet Cell Transplants for Diabetes
NCT00303134
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
NCT00195156
Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus
NCT00066716
COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM)
NCT01443637
The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans
NCT00227201
Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS
NCT00195000
The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers
NCT00248911
Avon Foundation Program to Improve Quality of Life in Breast Cancer Survivors
NCT00278837
Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study
NCT00161603
Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study
NCT00227175
Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study
NCT00195065
Research Evaluating the Value of Augmenting Medication With Psychotherapy
NCT00057551
Weekly Topotecan Therapy in Patients With Ovarian Cancer
NCT00194935
Study of Pharmacotherapy of Psychotic Depression
NCT00056472
Treatment of Polycythemia Vera With Gleevec
NCT01120821
Combined Agent Randomized Trial of Induction of Labor
NCT00504465
Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients
NCT00195052
Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients
NCT00151372
Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
NCT00194857
Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics
NCT00229671
Outcomes Of Social Service Programs For Homebound Older Adults
NCT00248924
A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
NCT00194987
Non-Invasive Targeted Electronic Pain Control Device ("Biowave System") Versus Transcutaneous Electrical Nerve Stimulation (TENS) for the Symptomatic Treatment of Chronic Low Back Pain
NCT00277797
Effects of Cerebral Oxygen Saturation on Neuropsychological Outcomes
NCT00151307
Ambulatory Care Characteristics as Predictors of Mortality and Re-Admission
NCT00224172
Psychodynamic Therapy for Treating Panic Disorder
NCT00128388
Prevention of Suicide in Primary Care Elderly: Collaborative Trial (PROSPECT)
NCT00279682
Improving Health Behavior and Outcomes After Angioplasty
NCT00248976
Assessing Pain as a Mediator of Behavior Change in Post-coronary Angioplasty Patients
NCT01469780
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
NCT00003656
The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients
NCT00226265
Prevention of Suicide in the Elderly
NCT00000367
Hospital Outcomes: Intervention in Moderately III Patients
NCT00256659
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00003391
Prognostic Measures in Ambulatory Care Settings
NCT00195130
Improving Outcomes and Quality of Life After CABG
NCT00256620
A Comparison of Primary Care and Traditional Internal Medicine Residents
NCT00224224
Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)
NCT00248885
A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002407
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.